[1] Zhang CY,Yuan WG,He P,et al.Liver fibrosis and hepatic stellate cells:Etiology,pathological hallmarks and therapeutic targets. World J Gastroenterol,2016,22(48):10512-10522. [2] Hürtgen Susanne M,Georg S,Karsten J,et al.Perforation as a delayed complication after endoscopic full-thickness resection in a recurrent adenoma of the sigmoid. Z Gastroenterol,2019,57:156-159. [3] Ayvaz S,Tuncel S A,Can G,et al.Efficacy of diffusion weighted magnetic resonance imaging in the evaluation of extrahepatic cholestasis-related hepatic fibrosis. Turk J Med Sci,2015,45(3):686. [4] Dunst D,Ream J M,Khalef V,et al.Comparison of MRI features of pathologically proven hepatocellular carcinoma between patients with hepatitis C and hepatitis B infection. Clin Imaging,2016,40(3):352. [5] Sujit S,Allen Christopher J,Farrell David E,et al.Measurement of the liver iron concentration in transfusional iron overload by MRI R2 and by high-transition-temperature superconducting magnetic susceptometry. Clin Imaging,2019,55:65-70. [6] Chin JL,Pavlides M,Moolla A,et al.Non-invasive markers of liver fibrosis:adjuncts or alternatives to liver biopsy Front Pharmacol,2016,7(159):1-19. [7] Almpanis Z,Demonakou M,Tiniakos D.Evaluation of liver fibrosis:‘Something old,something new…’. Ann Gastroenterol,2016,29:445-453. [8] Wang Y,He HH,Chang JT,et al.Mueller matrix microscope:a quantitative tool to facilitate detections and fibrosis scorings of liver cirrhosis and cancer tissues. J Biomed Opt,2016,21:71112. [9] Petitclerc L,Sebastiani G,Gilbert G,et al.Liver fibrosis:Review of current imaging and MRI quantification techniques. Magn Reson Imaging,2017,45:1276-1295. [10] Panel A H G. Hepatitis C guidance:AASLD-IDSA recommendations for testing,managing and treating adults infected with hepatitis C virus. Hepatology,2015,62(3):932-954. [11] Wen P,Zhao JY,Chen WZ.Effect of biological characteristics of different types of uterine fibroids,as assessed with T2 weighted magnetic resonance imaging,on ultrasound-guided high-intensity focused ultrasound ahlation. Ultrsound Med Biol,2015,41:423-431. [12] Cao MQ,Qian LJ,Zhang XB,et al.Monitoring leiomyoma response to uterine artery embolization using diffusion and perfusion indices from diffusion-weighted imaging. Biomed Res Int,2017,2017:3805073. [13] Vanbeers B E,Daibe J,Garteiser P.New imaging techniques for liver diseases. J Hepatol,2015,62(3):690-700. [14] Lee S H,Hayano K,Zhu A X,et al.Dynamic contrast-enhanced MRI kinetic parameters as prognostic biomarkers for prediction of survival of patient with advanced hepatocellular carcinoma:A pilot comparative study. Acad Radiol,2015,22(11):1344-1360. [15] Min JY,Park HS,Kim YJ,et al.Estimation of hepatic fat fraction using modified Dixon magnetic resonance imaging techniques:effect of liver cirrhosis. Clin Imaging,2018,51:50-58. [16] 张自成,梅冬雪,刘斌,等. 双环醇联合异甘草酸镁治疗失代偿期肝硬化疗效观察. 中华实用诊断与治疗杂志,2017,31(1):76-78. [17] 章俞,赵振华,赵丽,等. Extended Tofts和Exchange模型的动态对比增强MRI参数鉴别诊断肝细胞癌和肝转移瘤的价值. 中华放射学杂志,2015,49:656-660. [18] Li Z,Sun J,Chen L,et al.Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging,2016,44(1):98-104. [19] 周静,苏菲. 失代偿期肝硬化患者肝损伤急性加重100例临床分析. 实用肝脏病杂志,2016,19(3):314-317. [20] 王治冲,宋风斌. 失代偿期乙型肝炎肝硬化患者营养状况分析. 实用肝脏病杂志,2017,20(2):236-237. |